Relative to its peers, OGEN does not have very much institutional sponsorship. The 10.22% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BRIDGEWAY CAPITAL MANAGEMENT, IN... Bought 128.7 Thousand shares of Oragenics Inc
BROWN ADVISORY LLC Bought 50.0 Thousand shares of Oragenics Inc
CITADEL ADVISORS LLC Bought 20.2 Thousand shares of Oragenics Inc